Latest Headlines

  1. Implant Maker RTI Surgical To Acquire Zyga Technology

    RTI Surgical, Inc., a global surgical implant company, recently signed an agreement to acquire Zyga Technology, Inc., with closing subject to filing with the state of Delaware.

  2. Toshiba Medical Systems Corporation Rebranded As Canon Medical Systems Corporation

    Canon Inc. and Canon Medical Systems Corporation recently announced the official corporate name (trade name) change of Canon Group Company Toshiba Medical Systems Corporation to Canon Medical Systems Corporation (hereafter referred to as Canon Medical Systems).

  3. Bristol Instruments Introduces New Quick Align Probe For Non-Contact Thickness Measurement

    Bristol Instruments, Inc., the leader in optical interferometer-based instrumentation, has announced the introduction of its QA—“Quick- Align”—optical probe. This new probe, used in combination with Bristol’s 137 and 157 Optical Thickness Gauge products, offers the advantage of a unique alignment aid to ensure the reliable accuracy and exceptional repeatability needed for the most demanding thickness measurement applications.

  4. Medical Design Engineers’ Adhesive Selection Process Made Easier With New 3M Product Selector Tool

    Adhesives play a critical role in the success of a medical device, whether it’s holding the device together or adhering it to the wearer’s skin. But with so many adhesive products available, it can be a challenge for design engineers to know which one is right for their project. To help bridge this critical gap, 3M developed a “Find My Adhesive” product selector tool to help make medical adhesive selection a simpler process. The product selector tool will be available to demo at CES 2018 in Las Vegas from January 9-12, 2018 in the 3M booth located in Sands, Halls A-D; 43517 Health & Wellness Marketplace.

  5. FDA Clears Mevion’s Proton Therapy System

    Mevion Medical Systems has received FDA 510(k) clearance for the MEVION S250i Proton Therapy System® including HYPERSCAN pencil beam scanning (PBS) technology. 

  6. FDA Clears Zimmer Biomet’s Total Shoulder Arthroplasty System

    Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the Sidus® Stem-Free Shoulder system as a total shoulder arthroplasty solution for patients with good bone stock that have either osteoarthritis, post-traumatic arthrosis, focal avascular necrosis of the humeral head or who had previous surgeries of the shoulder that do not compromise the fixation.

  7. An Organ-On-A-Chip Device That Models Heart Disease

    When studying diseases or testing potential drug therapies, researchers usually turn to cultured cells on Petri dishes or experiments with lab animals, but recently, researchers have been developing a different approach: small, organ-on-a-chip devices that mimic the functions of human organs, serving as potentially cheaper and more effective tools.

  8. Nanowire Device Holds Promise To Detect Cancer With A Urine Test

    Cells communicate with each other through a number of different mechanisms. Some of these mechanisms are well-known: in animals, for example, predatory threats can drive the release of norepinephrine, a hormone that travels through the bloodstream and triggers heart and muscle cells to initiate a "fight-or-flight" response.

  9. K2M’s 3D-Printed Expandable Corpectomy Cage With Cervical Spine Indications Gains CE Mark

    K2M Group Holdings, Inc.(NASDAQ:KTWO) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three-dimensional Total Body Balance™, today announced that it received a CE Mark for its CAPRI® Cervical 3D Expandable Corpectomy Cage System* featuring Lamellar 3D Titanium Technology™, and the successful completion of its first surgical case.

  10. Developing The First Pediatric Heart Valve Designed To “Grow” With The Child

    Each year 40,000 babies in the U.S. are born with a congenital heart defect, often caused by a defective heart valve, which is estimated to account for 8,000 to 13,000 new cases in the U.S. alone.